Open | $4.580 |
Close | $4.540 |
Volume / Avg. | 100.486K / 24.440K |
Day Range | 4.510 - 5.040 |
52 Wk Range | 4.245 - 111.000 |
Market Cap | $69.293M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 19 |
Short Interest | 10.73% |
Days to Cover | 2.98 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Affimed (NASDAQ: AFMD) through any online brokerage.
There are no as such competitors for Affimed.
The latest price target for Affimed (NASDAQ: AFMD) was reported by HC Wainwright & Co. on Wednesday, November 15, 2023. The analyst firm set a price target for 5.00 expecting AFMD to rise to within 12 months (a possible 7.76% upside). 12 analyst firms have reported ratings in the last year.
The stock price for Affimed (NASDAQ: AFMD) is $4.64 last updated March 18, 2024 at 7:02 PM EDT.
There are no upcoming dividends for Affimed.
Affimed’s Q1 earnings are confirmed for Tuesday, May 21, 2024.
There is no upcoming split for Affimed.
Affimed is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.